• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Rogers Corporation Reports Fourth Quarter and Full Year 2025 Results

    2/17/26 4:04:00 PM ET
    $ROG
    Major Chemicals
    Industrials
    Get the next $ROG alert in real time by email
    • Net sales of $810.8 million in 2025 and $201.5 million for the fourth quarter
    • Gross margin of 31.7% in 2025 and 31.5% for the fourth quarter
    • Net income (loss) of $(61.8) million in 2025 and $4.6 million for the fourth quarter
    • Adjusted EBITDA of $115.0 million in 2025 and $34.4 million for the fourth quarter
    • Loss per share of $(3.40) in 2025 and earnings per share of $0.26 for the fourth quarter
    • Adjusted earnings per share of $2.39 in 2025 and $0.89 for the fourth quarter

    Rogers Corporation (NYSE:ROG) today announced financial results for the full year and fourth quarter of 2025.

    "Solid execution led to sales, gross margin and adjusted earnings per share that approached or exceeded the high-end of guidance for the fourth quarter," stated Ali El-Haj, Rogers' Interim President and CEO. "We are encouraged that the benefits of cost improvement initiatives implemented in recent quarters are contributing to significantly higher adjusted earnings per share compared with the same period last year."

    "Rogers enters 2026 in a strong position with a streamlined operating structure, an enhanced innovation strategy, and a healthy balance sheet which we expect will enable a return to growth and meaningfully improved results for shareholders."

    Financial Overview

     

    GAAP Results (dollars in millions, except per share amounts)

    Q4 2025

    Q3 2025

    Q4 2024

    2025

    2024

    Net Sales

    $201.5

    $216.0

    $192.2

    $810.8

    $830.1

    Gross Margin

    31.5%

    33.5%

    32.1%

    31.7%

    33.4%

    Net Income (Loss)

    $4.6

    $8.6

    $(0.5)

    $(61.8)

    $26.1

    Diluted Earnings (Loss) Per Share

    $0.26

    $0.48

    $(0.03)

    $(3.40)

    $1.40

    Adjusted Earnings Per Diluted Share1

    $0.89

    $0.90

    $0.46

    $2.39

    $2.72

    Adjusted EBITDA1

    $34.4

    $37.2

    $23.3

    $115.0

    $118.7

    Net Cash Provided by Operating Activities

    $46.9

    $28.9

    $33.7

    $101.2

    $127.1

    Free Cash Flow1

    $42.2

    $21.2

    $18.3

    $71.1

    $71.0

     

    1 - Adjusted Earnings Per Diluted Share, Adjusted EBITDA and Free Cash Flow are non-GAAP measures. A reconciliation of non-GAAP to GAAP measures is provided in the schedules included below.

    Q4 2025 Summary of Results

    Net sales of $201.5 million increased 4.8% versus the prior year quarter primarily from higher industrial, ADAS and renewable energy sales. Currency exchange rates favorably affected total Company net sales in the fourth quarter of 2025 by $3.7 million compared to the fourth quarter of 2024.

    GAAP earnings per diluted share were $0.26 compared to a loss per share of $(0.03) in Q4 2024. On an adjusted basis, earnings were $0.89 per diluted share compared to earnings of $0.46 per diluted share in the prior year quarter. The improvement in adjusted earnings resulted from higher sales and lower operating expenses.

    Fourth quarter ending cash and cash equivalents were $197.0 million, an increase of $29.2 million compared to the prior quarter. Net cash provided by operating activities was $46.9 million and increased by $18.0 million due to lower inventories and other working capital improvements. Share repurchases totaled $14.3 million and capital expenditures were $4.7 million.

    Financial Outlook

    At the mid-point of the guidance for the first quarter of 2026 the Company expects 5% sales growth, a 160 basis point improvement in gross margin and a 530 basis point increase in adjusted EBITDA margin, compared to Q1 2025.

    (dollars in millions, except per share amounts)

    Q1 2026

    Net Sales

    $193 to $208

    Gross Margin

    30.5% to 32.5%

    Adjusted Earnings Per Diluted Share

    $0.45 to $0.85

    Adjusted EBITDA

    $27 to $35

     

     

     

    2026

    Capital Expenditures

    $30 to $40

    Conference Call and Additional Information

    A conference call to discuss the results for the fourth quarter and full year will take place today, Tuesday, February 17, 2026 at 5:00 pm ET. A live webcast of the event and the accompanying presentation can be accessed on the Rogers Corporation website at https://www.rogerscorp.com/investors.

    About Rogers Corporation

    Rogers Corporation (NYSE:ROG) is a global leader in engineered materials to power, protect and connect our world. Rogers delivers innovative solutions to help our customers solve their toughest material challenges. Rogers' advanced electronic and elastomeric materials are used in applications for EV/HEV, automotive safety and radar systems, mobile devices, renewable energy, wireless infrastructure, energy-efficient motor drives, industrial equipment and more. Headquartered in Chandler, Arizona, Rogers operates manufacturing facilities in the United States (U.S.), Asia and Europe, with sales offices worldwide.

    Safe Harbor Statement

    Statements included in this release that are not a description of historical facts are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such statements are generally accompanied by words or phrases such as "anticipate," "assume," "believe," "could," "estimate," "expect," "foresee," "goal," "intend," "may," "might," "plan," "potential," "predict," "project," "should," "seek," "target" or similar expressions that convey uncertainty as to the future events or outcomes. Forward-looking statements are based on assumptions and beliefs that we believe to be reasonable; however, assumed facts almost always vary from actual results, and the differences between assumed facts and actual results could be material depending upon the circumstances. Where we express an expectation or belief as to future results, that expectation or belief is expressed in good faith and based on assumptions believed to have a reasonable basis. We cannot assure you, however, that the stated expectation or belief will occur or be achieved or accomplished. This release contains forward-looking statements regarding our plans, objectives, outlook, goals, strategies, future events, future net sales or performance, capital expenditures, future restructuring, plans or intentions relating to expansions, business trends and other information that is not historical information. All forward-looking statements are based upon information available to us on the date of this release and are subject to risks, uncertainties and other factors, many of which are outside of our control, which could cause actual results to differ materially from those indicated by the forward-looking statements. Other risks and uncertainties that could cause such results to differ include the following, without limitation: failure to capitalize on, volatility within, or other adverse changes with respect to growth opportunities, such as delays in adoption or implementation of new technologies; uncertain business, economic and political conditions in the U.S. and abroad, particularly in China, Germany, England, Belgium, South Korea and Hungary, where we maintain significant manufacturing, sales or administrative operations; the global trade policy dynamics between nations reflected in trade agreement negotiations, imposition of tariffs and other trade restrictions, as well as the potential for global supply chain decoupling; fluctuations in foreign currency exchange rates; our ability to develop innovative products and the extent to which they are incorporated into end-user products and systems that achieve commercial success; the ability and willingness of our sole or limited source suppliers to deliver certain key raw materials, including commodities, to us in a timely and cost-effective manner; business interruptions due to catastrophes or other similar events, such as natural disasters, war, terrorism or public health crises; the impact of sanctions, export controls and other foreign asset or investment restrictions; failure to realize, or delays in the realization of anticipated benefits of acquisitions and divestitures due to, among other things, the existence of unknown liabilities or difficulty integrating acquired businesses; our ability to attract and retain management and skilled technical personnel; our ability to protect our proprietary technology from infringement by third parties and/or allegations that our technology infringes third party rights; changes in effective tax rates or tax laws and regulations in the jurisdictions in which we operate; failure to comply with financial and restrictive covenants in our credit agreement or restrictions on our operational and financial flexibility due to such covenants; the outcome of ongoing and future litigation, including our asbestos-related product liability litigation; changes in environmental laws and regulations applicable to our business; and disruptions in, or breaches of, our information technology systems. Should any risks and uncertainties develop into actual events, these developments could have a material adverse effect on the Company. Our forward-looking statements are expressly qualified by these cautionary statements, which you should consider carefully. For additional information about the risks, uncertainties and other factors that may affect our business, please see our most recent annual report on Form 10-K and any subsequent reports filed with the Securities and Exchange Commission, including quarterly reports on Form 10-Q. Rogers Corporation assumes no responsibility to update or revise any forward-looking statements contained herein, whether as a result of new information, future events or otherwise, except as required by law.

    (Financial statements follow)

    Condensed Consolidated Statements of Operations (Unaudited)

    (DOLLARS AND SHARES IN MILLIONS, EXCEPT PER SHARE AMOUNTS)

     

    Three Months Ended

     

    Twelve Months Ended

     

    December 31, 2025

     

    December 31, 2024

     

    December 31, 2025

     

    December 31, 2024

    Net sales

    $

    201.5

     

     

    $

    192.2

     

     

    $

    810.8

     

     

    $

    830.1

     

    Cost of sales

     

    138.0

     

     

     

    130.5

     

     

     

    554.0

     

     

     

    553.0

     

    Gross margin

     

    63.5

     

     

     

    61.7

     

     

     

    256.8

     

     

     

    277.1

     

     

     

     

     

     

     

     

     

    Selling, general and administrative expenses

     

    42.0

     

     

     

    49.9

     

     

     

    176.6

     

     

     

    193.4

     

    Research and development expenses

     

    6.6

     

     

     

    8.1

     

     

     

    28.1

     

     

     

    34.6

     

    Restructuring and impairment charges

     

    8.0

     

     

     

    16.3

     

     

     

    97.1

     

     

     

    24.1

     

    Other operating (income) expense, net

     

    (0.2

    )

     

     

    0.1

     

     

     

    —

     

     

     

    0.1

     

    Operating income (loss)

     

    7.1

     

     

     

    (12.7

    )

     

     

    (45.0

    )

     

     

    24.9

     

     

     

     

     

     

     

     

     

    Equity income in unconsolidated joint ventures

     

    —

     

     

     

    0.2

     

     

     

    —

     

     

     

    1.4

     

    Other income (expense), net

     

    2.5

     

     

     

    9.6

     

     

     

    (0.9

    )

     

     

    8.8

     

    Interest income (expense), net

     

    (0.1

    )

     

     

    0.2

     

     

     

    0.8

     

     

     

    (0.8

    )

    Income (loss) before income taxes

     

    9.5

     

     

     

    (2.7

    )

     

     

    (45.1

    )

     

     

    34.3

     

    Income tax (benefit) expense

     

    4.9

     

     

     

    (2.2

    )

     

     

    16.7

     

     

     

    8.2

     

    Net income (loss)

    $

    4.6

     

     

    $

    (0.5

    )

     

    $

    (61.8

    )

     

    $

    26.1

     

     

     

     

     

     

     

     

     

    Basic earnings (loss) per share

    $

    0.26

     

     

    $

    (0.03

    )

     

    $

    (3.40

    )

     

    $

    1.40

     

    Diluted earnings (loss) per share

    $

    0.26

     

     

    $

    (0.03

    )

     

    $

    (3.40

    )

     

    $

    1.40

     

     

     

     

     

     

     

     

     

    Shares used in computing:

     

     

     

     

     

     

     

    Basic earnings (loss) per share

     

    17.9

     

     

     

    18.6

     

     

     

    18.2

     

     

     

    18.6

     

    Diluted earnings (loss) per share

     

    18.0

     

     

     

    18.6

     

     

     

    18.2

     

     

     

    18.6

     

    Condensed Consolidated Statements of Financial Position (Unaudited)

    (DOLLARS AND SHARES IN MILLIONS, EXCEPT PAR VALUE)

    December 31, 2025

     

    December 31, 2024

    Assets

     

     

     

    Current assets

     

     

     

    Cash and cash equivalents

    $

    197.0

     

     

    $

    159.8

     

    Accounts receivable, net

     

    130.6

     

     

     

    135.3

     

    Contract assets

     

    27.9

     

     

     

    23.7

     

    Inventories, net

     

    125.0

     

     

     

    142.3

     

    Asbestos-related insurance recoverables, current portion

     

    4.7

     

     

     

    4.3

     

    Other current assets

     

    14.8

     

     

     

    28.5

     

    Total current assets

     

    500.0

     

     

     

    493.9

     

    Property, plant and equipment, net of accumulated depreciation

     

    372.4

     

     

     

    365.1

     

    Operating lease right-of-use assets

     

    19.2

     

     

     

    24.1

     

    Goodwill

     

    303.4

     

     

     

    357.6

     

    Intangible assets, net of accumulated amortization

     

    99.3

     

     

     

    110.3

     

    Asbestos-related insurance recoverables, non-current portion

     

    48.1

     

     

     

    48.0

     

    Deferred income taxes

     

    67.0

     

     

     

    61.5

     

    Other long-term assets

     

    20.5

     

     

     

    20.6

     

    Total assets

    $

    1,429.9

     

     

    $

    1,481.1

     

    Liabilities and Shareholders' Equity

     

     

     

    Current liabilities

     

     

     

    Accounts payable

    $

    42.9

     

     

    $

    48.1

     

    Accrued employee benefits and compensation

     

    43.2

     

     

     

    41.5

     

    Accrued income taxes payable

     

    10.2

     

     

     

    7.7

     

    Operating lease obligations, current portion

     

    3.9

     

     

     

    4.0

     

    Asbestos-related liabilities, current portion

     

    5.5

     

     

     

    5.4

     

    Other accrued liabilities

     

    20.4

     

     

     

    16.8

     

    Total current liabilities

     

    126.1

     

     

     

    123.5

     

    Operating lease obligations, non-current portion

     

    17.9

     

     

     

    20.6

     

    Asbestos-related liabilities, non-current portion

     

    51.9

     

     

     

    52.1

     

    Non-current income tax

     

    4.8

     

     

     

    5.7

     

    Deferred income taxes

     

    17.7

     

     

     

    18.0

     

    Other long-term liabilities

     

    15.8

     

     

     

    9.6

     

    Shareholders' equity

     

     

     

    Capital stock - $1 par value; 50.0 authorized shares; 17.8 and 18.5 shares issued and outstanding, respectively

     

    17.8

     

     

     

    18.5

     

    Additional paid-in capital

     

    105.7

     

     

     

    147.3

     

    Retained earnings

     

    1,119.3

     

     

     

    1,181.1

     

    Accumulated other comprehensive loss

     

    (47.1

    )

     

     

    (95.3

    )

    Total shareholders' equity

     

    1,195.7

     

     

     

    1,251.6

     

    Total liabilities and shareholders' equity

    $

    1,429.9

     

     

    $

    1,481.1

     

    Reconciliation of non-GAAP financial measures to the comparable GAAP measures

    Non-GAAP Financial Measures:

    This earnings release includes the following financial measures that are not presented in accordance with generally accepted accounting principles in the United States of America ("GAAP"):

    (1) Adjusted earnings per diluted share, which the Company defines as earnings (loss) per diluted share excluding acquisition and related integration costs, dispositions, intangible amortization, (gains) losses on the sale or disposal of property, plant and equipment, restructuring, severance, impairment and other related costs, asbestos-related charges (credits), and the related income tax effect on these items, and charges to income tax expense for valuation allowances on deferred tax assets generated in prior years, divided by adjusted weighted average shares outstanding - diluted;

    (2) Adjusted EBITDA, which the Company defines as net income (loss) excluding acquisition and related integration costs, dispositions, intangible amortization, (gains) losses on the sale or disposal of property, plant and equipment, restructuring, severance, impairment and other related costs, asbestos-related charges (credits), interest income (expense), net, income tax (benefit) expense , depreciation of fixed assets, and equity compensation expense;

    (3) Adjusted EBITDA Margin, which the Company defines as the percentage that results from dividing Adjusted EBITDA by total net sales;

    (4) Free cash flow, which the Company defines as net cash provided by operating activities less non-acquisition capital expenditures.

    Management believes adjusted earnings per diluted share, adjusted EBITDA and adjusted EBITDA margin are useful to investors because they allow for comparison to the Company's performance in prior periods without the effect of items that, by their nature, tend to obscure the Company's core operating results due to potential variability across periods based on the timing, frequency and magnitude of such items. As a result, management believes that these measures enhance the ability of investors to analyze trends in the Company's business and evaluate the Company's performance relative to peer companies. Management also believes free cash flow is useful to investors as an additional way of viewing the Company's liquidity and provides a more complete understanding of factors and trends affecting the Company's cash flows. However, non-GAAP financial measures have limitations as analytical tools and should not be considered in isolation from, or as alternatives to, financial measures prepared in accordance with GAAP. In addition, these non-GAAP financial measures may differ from, and should not be compared to, similarly named measures used by other companies. Reconciliations of the differences between these non-GAAP financial measures and their most directly comparable financial measures calculated in accordance with GAAP are set forth below.

    The Company provides first quarter 2026 guidance for adjusted earnings per diluted share and adjusted EBITDA on a non-GAAP basis only. The forward-looking comparable GAAP measures and a reconciliation of adjusted earnings per share and adjusted EBITDA to GAAP are excluded in reliance upon the exception provided by Item 10(e)(1)(i)(B) of Regulation S-K due to the inherent difficulty in forecasting and quantifying, without unreasonable efforts, certain reconciling items. These include, among other things, adjustments that could be made for acquisition and related integration costs, dispositions, intangible amortization, (gains) losses on the sale or disposal of property, plant and equipment, restructuring, severance, impairment and other related costs, asbestos-related charges (credits), and charges to income tax expense for valuation allowances on deferred tax assets generated in prior years, and other charges reflected in the Company's reconciliations of historic numbers, the amount of which, based on historical experience, could be significant.

    Reconciliation of GAAP Earnings (Loss) Per Diluted Share to Adjusted Earnings Per Diluted Share*:

     

    2025

    2024

     

    Q4

    Q3

    YTD

    Q4

    YTD

    GAAP Earnings (Loss) Per Diluted Share

    $

    0.26

     

    $

    0.48

     

    $

    (3.40

    )

    $

    (0.03

    )

    $

    1.40

     

     

     

     

     

     

     

    Acquisition & Divestiture Related Costs:

     

     

     

     

     

    Acquisition & Related Integration Costs

     

    —

     

     

    —

     

     

    —

     

     

    (0.40

    )

     

    (0.40

    )

    Intangible Amortization

     

    0.16

     

     

    0.15

     

     

    0.60

     

     

    0.17

     

     

    0.67

     

    (Gain) Loss on Sale or Disposal of PPE

     

    —

     

     

    —

     

     

    —

     

     

    0.01

     

     

    0.01

     

     

     

     

     

     

     

    Restructuring, Business Realignment & Other Cost Saving Initiatives:

     

     

     

     

     

    Restructuring, Severance, Impairment & Other Related Costs

     

    0.44

     

     

    0.39

     

     

    5.34

     

     

    0.91

     

     

    1.51

     

     

     

     

     

     

     

    Asbestos-Related Charges (Credits)

     

    —

     

     

    —

     

     

    —

     

     

    0.08

     

     

    0.08

     

     

     

     

     

     

     

    Valuation Allowances against Deferred Tax Assets

     

    (0.05

    )

     

    —

     

     

    0.16

     

     

    —

     

     

    —

     

     

     

     

     

     

     

    Estimated Income Tax Impacts of Adjustments

     

    0.09

     

     

    (0.13

    )

     

    (0.31

    )

     

    (0.27

    )

     

    (0.54

    )

    Impact of Including Dilutive Securities

     

    —

     

     

    —

     

     

    —

     

     

    —

     

     

    —

     

    Total Adjustments

    $

    0.64

     

    $

    0.41

     

    $

    5.78

     

    $

    0.49

     

    $

    1.31

     

    Adjusted Earnings Per Diluted Share

    $

    0.89

     

    $

    0.90

     

    $

    2.39

     

    $

    0.46

     

    $

    2.72

     

    *Values in table may not add due to rounding.

    The following table reconciles weighted average shares outstanding - diluted under US GAAP to adjusted weighted average shares outstanding - diluted used in the calculation of adjusted diluted EPS:

     

    2025

    2024

    (shares in millions)

    Q4

    Q3

    YTD

    Q4

    YTD

    Weighed average shares outstanding - diluted

    18.0

    18.1

    18.2

    18.6

    18.6

    Dilutive effect of awards under equity compensation plans

    —

    —

    —

    —

    —

    Adjusted weighted average shares outstanding - diluted

    18.0

    18.1

    18.2

    18.6

    18.6

    Reconciliation of GAAP Net Income (Loss) to Adjusted EBITDA*:

     

    2025

    2024

    (dollars in millions)

    Q4

    Q3

    YTD

    Q4

    YTD

    GAAP Net Income (Loss)

    $

    4.6

    $

    8.6

     

    $

    (61.8

    )

    $

    (0.5

    )

    $

    26.1

     

     

     

     

     

     

     

    Acquisition & Divestiture Related Costs:

     

     

     

     

     

    Acquisition & Related Integration Costs

     

    —

     

    —

     

     

    —

     

     

    (7.5

    )

     

    (7.5

    )

    Dispositions

     

    —

     

    —

     

     

    —

     

     

    —

     

     

    —

     

    Intangible Amortization

     

    2.8

     

    2.8

     

     

    11.0

     

     

    3.1

     

     

    12.4

     

    (Gain) Loss on Sale or Disposal of PPE

     

    —

     

    —

     

     

    —

     

     

    0.1

     

     

    0.1

     

     

     

     

     

     

     

    Restructuring, Business Realignment & Other Cost Saving Initiatives:

     

     

     

     

     

    Restructuring, Severance, Impairment & Other Related Costs

     

    8.0

     

    7.1

     

     

    97.1

     

     

    16.9

     

     

    28.0

     

     

     

     

     

     

     

    Asbestos-Related Charges (Credits)

     

    —

     

    —

     

     

    —

     

     

    1.4

     

     

    1.4

     

     

     

     

     

     

     

    Interest (Income) Expense, net

     

    0.1

     

    (0.2

    )

     

    (0.8

    )

     

    (0.2

    )

     

    0.8

     

    Income Tax (Benefit) Expense

     

    4.9

     

    7.7

     

     

    16.7

     

     

    (2.2

    )

     

    8.2

     

    Depreciation

     

    11.8

     

    10.4

     

     

    41.9

     

     

    9.3

     

     

    34.1

     

    Equity Compensation

     

    2.2

     

    0.8

     

     

    10.9

     

     

    2.9

     

     

    15.1

     

    Total Adjustments

    $

    29.8

    $

    28.6

     

    $

    176.8

     

    $

    23.8

     

    $

    92.6

     

    Adjusted EBITDA

    $

    34.4

    $

    37.2

     

    $

    115.0

     

    $

    23.3

     

    $

    118.7

     

    *Values in table may not add due to rounding.

    Calculation of Adjusted EBITDA margin*:

     

    2025

    2024

    (dollars in millions)

    Q4

    Q3

    YTD

    Q4

    YTD

    Adjusted EBITDA

    $

    34.4

     

    $

    37.2

     

    $

    115.0

     

    $

    23.3

     

    $

    118.7

     

    Divided by Total Net Sales

     

    201.5

     

     

    216.0

     

     

    810.8

     

     

    192.2

     

     

    830.1

     

    Adjusted EBITDA Margin

     

    17.1

    %

     

    17.2

    %

     

    14.2

    %

     

    12.1

    %

     

    14.3

    %

    *Values in table may not add due to rounding.

    Reconciliation of Net Cash Provided By Operating Activities to Free Cash Flow:

     

    2025

    2024

    (dollars in millions)

    Q4

    Q3

    YTD

    Q4

    YTD

    Net Cash Provided By Operating Activities

    $

    46.9

     

    $

    28.9

     

    $

    101.2

     

    $

    33.7

     

    $

    127.1

     

    Non-Acquisition Capital Expenditures

     

    (4.7

    )

     

    (7.7

    )

     

    (30.1

    )

     

    (15.4

    )

     

    (56.1

    )

    Free Cash Flow

    $

    42.2

     

    $

    21.2

     

    $

    71.1

     

    $

    18.3

     

    $

    71.0

     

     

    View source version on businesswire.com: https://www.businesswire.com/news/home/20260217814875/en/

    Investor Contact:

    Steve Haymore

    Phone: 480-917-6026

    Email: [email protected]



    Website Address: https://www.rogerscorp.com

    Get the next $ROG alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ROG

    DatePrice TargetRatingAnalyst
    3/31/2025$85.00Buy
    CL King
    3/14/2023$185.00Market Outperform
    CJS Securities
    2/14/2023$180.00Buy
    B. Riley Securities
    12/14/2021$277.00Market Outperform → Market Perform
    CJS Securities
    11/4/2021$225.00 → $277.00Buy → Hold
    Stifel
    11/4/2021$233.00 → $277.00Buy → Hold
    Canaccord Genuity
    11/3/2021Outperform → Peer Perform
    Wolfe Research
    7/30/2021$260.00 → $233.00Buy
    Canaccord Genuity
    More analyst ratings

    $ROG
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    New survey demonstrates how diabetes limits day-to-day freedom for people around the world and highlights need for predictive tools

    Global survey of 4,326 people with diabetes shows how the unpredictability and mental burden associated with managing the condition negatively impacts daily life.1Majority of respondents say that constantly planning around blood glucose levels, meal times, and medication schedules interfere with routine activities from childcare and work, to sport and travelling.1 Eight in ten respondents say that they would value predictive tools that, for example, can predict glucose changes before they occur.1BASEL, Switzerland, March 5, 2026 /PRNewswire/ -- Roche ((SIX: RO, ROG, OTCQX:RHHBY) announced today findings from a global survey of 4,326 people with diabetes across 22 countries, exploring the log

    3/5/26 1:15:00 AM ET
    $ROG
    Major Chemicals
    Industrials

    Rogers Corporation Reports Fourth Quarter and Full Year 2025 Results

    Net sales of $810.8 million in 2025 and $201.5 million for the fourth quarter Gross margin of 31.7% in 2025 and 31.5% for the fourth quarter Net income (loss) of $(61.8) million in 2025 and $4.6 million for the fourth quarter Adjusted EBITDA of $115.0 million in 2025 and $34.4 million for the fourth quarter Loss per share of $(3.40) in 2025 and earnings per share of $0.26 for the fourth quarter Adjusted earnings per share of $2.39 in 2025 and $0.89 for the fourth quarter Rogers Corporation (NYSE:ROG) today announced financial results for the full year and fourth quarter of 2025. "Solid execution led to sales, gross margin and adjusted earnings per share that approached

    2/17/26 4:04:00 PM ET
    $ROG
    Major Chemicals
    Industrials

    Rogers Corporation Schedules Fourth Quarter 2025 Earnings Call for February 17

    Rogers Corporation (NYSE:ROG) ("Rogers") plans to announce fourth quarter and full year 2025 results on February 17, 2026 after market close, which will be followed by a conference call at 5:00 pm ET. The call will be hosted by Ali El-Haj, Interim President and Chief Executive Officer, who will be joined by Laura Russell, Senior Vice President and Chief Financial Officer. A live webcast of the event and related slide presentation can be accessed on Rogers' Investor Relations website at https://www.rogerscorp.com/investors. A replay of the event will also be available on the Investor Relations' website. About Rogers Corporation Rogers Corporation (NYSE:ROG) is a global leader in engine

    2/3/26 4:06:00 PM ET
    $ROG
    Major Chemicals
    Industrials

    $ROG
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    $ROG
    SEC Filings

    View All

    $ROG
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    CL King initiated coverage on Rogers Corp with a new price target

    CL King initiated coverage of Rogers Corp with a rating of Buy and set a new price target of $85.00

    3/31/25 8:27:47 AM ET
    $ROG
    Major Chemicals
    Industrials

    CJS Securities initiated coverage on Rogers Corp with a new price target

    CJS Securities initiated coverage of Rogers Corp with a rating of Market Outperform and set a new price target of $185.00

    3/14/23 9:35:13 AM ET
    $ROG
    Major Chemicals
    Industrials

    B. Riley Securities resumed coverage on Rogers Corp with a new price target

    B. Riley Securities resumed coverage of Rogers Corp with a rating of Buy and set a new price target of $180.00

    2/14/23 7:57:52 AM ET
    $ROG
    Major Chemicals
    Industrials

    Rogers Corporation filed SEC Form 8-K: Leadership Update

    8-K - ROGERS CORP (0000084748) (Filer)

    3/3/26 5:04:51 PM ET
    $ROG
    Major Chemicals
    Industrials

    SEC Form 10-K filed by Rogers Corporation

    10-K - ROGERS CORP (0000084748) (Filer)

    2/19/26 2:35:48 PM ET
    $ROG
    Major Chemicals
    Industrials

    Rogers Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - ROGERS CORP (0000084748) (Filer)

    2/17/26 4:07:16 PM ET
    $ROG
    Major Chemicals
    Industrials

    President of AES Tsao Jeff covered exercise/tax liability with 257 units of Capital Stock, decreasing direct ownership by 2% to 12,149 units (SEC Form 4)

    4 - ROGERS CORP (0000084748) (Issuer)

    3/2/26 6:00:27 PM ET
    $ROG
    Major Chemicals
    Industrials

    SVP, CFO, Treasurer Russell Laura covered exercise/tax liability with 456 units of Capital Stock, decreasing direct ownership by 3% to 12,615 units (SEC Form 4)

    4 - ROGERS CORP (0000084748) (Issuer)

    3/2/26 5:59:54 PM ET
    $ROG
    Major Chemicals
    Industrials

    Corporate Controller & CAO Reeder Raymond Sean covered exercise/tax liability with 69 units of Capital Stock, decreasing direct ownership by 4% to 1,818 units (SEC Form 4)

    4 - ROGERS CORP (0000084748) (Issuer)

    3/2/26 5:59:20 PM ET
    $ROG
    Major Chemicals
    Industrials

    $ROG
    Leadership Updates

    Live Leadership Updates

    View All

    Rogers Corporation Announces Transition of Board Chair and Plans to Add New Independent Director

    Rogers Corporation (NYSE:ROG) (the "Company") today announced that Peter Wallace, Chair of the Board of Directors (the "Board"), has informed the Board of his decision not to stand for re-election at the Company's 2026 Annual Meeting of Shareholders. In anticipation of this transition, the Board has elected Armand Lauzon, an existing member of the Board since 2023, to serve as the next Chair, effective immediately. Mr. Wallace will partner with Mr. Lauzon over the coming months to ensure a smooth transition. Mr. Wallace joined the Board in June 2010 and has served as Chair or Lead Director since 2019. "After 15 years of serving on the Board, I believe this is the right time for me to pr

    10/16/25 5:31:00 PM ET
    $ROG
    Major Chemicals
    Industrials

    Rogers Corporation Announces CEO Transition

    Rogers launches a search for permanent CEO and names Ali El-Haj as interim leader The Board of Directors of Rogers Corporation (NYSE:ROG) today announced that Colin Gouveia has left his position as President and CEO and has resigned from the Board on July 12, 2025. Ali El-Haj has been named the company's interim President and CEO. Mr. El-Haj brings global leadership experience in key Rogers markets and is well-positioned to advance the company's strategic direction during this transition. "Ali is an accomplished global leader with extensive experience in technical sectors and a strong track record of executing strategy in lean, high-performance environments," said Peter Wallace, Chair o

    7/14/25 9:00:00 AM ET
    $ROG
    Major Chemicals
    Industrials

    Rogers Appoints Laura Russell as Chief Financial Officer

    Rogers Corporation (NYSE:ROG) ("Rogers") announced today that Laura Russell has been appointed to serve as the Company's new Senior Vice President, Chief Financial Officer and Treasurer effective December 10. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241210039520/en/(Photo: Business Wire) "Since taking over as interim CFO in August, Laura has proven to be an invaluable addition to Rogers' senior executive team," said Colin Gouveia, Rogers' President and CEO. "She has demonstrated outstanding leadership of critical finance functions and has already made significant contributions. Laura brings extensive business and financial

    12/10/24 4:05:00 PM ET
    $ROG
    Major Chemicals
    Industrials

    $ROG
    Financials

    Live finance-specific insights

    View All

    Rogers Corporation Reports Fourth Quarter and Full Year 2025 Results

    Net sales of $810.8 million in 2025 and $201.5 million for the fourth quarter Gross margin of 31.7% in 2025 and 31.5% for the fourth quarter Net income (loss) of $(61.8) million in 2025 and $4.6 million for the fourth quarter Adjusted EBITDA of $115.0 million in 2025 and $34.4 million for the fourth quarter Loss per share of $(3.40) in 2025 and earnings per share of $0.26 for the fourth quarter Adjusted earnings per share of $2.39 in 2025 and $0.89 for the fourth quarter Rogers Corporation (NYSE:ROG) today announced financial results for the full year and fourth quarter of 2025. "Solid execution led to sales, gross margin and adjusted earnings per share that approached

    2/17/26 4:04:00 PM ET
    $ROG
    Major Chemicals
    Industrials

    Rogers Corporation Schedules Fourth Quarter 2025 Earnings Call for February 17

    Rogers Corporation (NYSE:ROG) ("Rogers") plans to announce fourth quarter and full year 2025 results on February 17, 2026 after market close, which will be followed by a conference call at 5:00 pm ET. The call will be hosted by Ali El-Haj, Interim President and Chief Executive Officer, who will be joined by Laura Russell, Senior Vice President and Chief Financial Officer. A live webcast of the event and related slide presentation can be accessed on Rogers' Investor Relations website at https://www.rogerscorp.com/investors. A replay of the event will also be available on the Investor Relations' website. About Rogers Corporation Rogers Corporation (NYSE:ROG) is a global leader in engine

    2/3/26 4:06:00 PM ET
    $ROG
    Major Chemicals
    Industrials

    Rogers Corporation Reports Third Quarter 2025 Results

    Net sales of $216.0 million increased 6.5% sequentially Gross margin of 33.5% increased 190 basis points sequentially Earnings per share of $0.48 compared to $(4.00) in the prior quarter Adjusted earnings per share of $0.90 compared to $0.34 in the prior quarter Rogers Corporation (NYSE:ROG) today announced financial results for the third quarter of 2025. "Third quarter results were at the upper end of guidance due to improved end-market demand and good execution on cost improvement initiatives," stated Ali El-Haj, Rogers' Interim President and CEO. "Compared to the prior quarter sales, gross margin, earnings, adjusted EBITDA and free cash flow all showed substantial improvem

    10/29/25 4:05:00 PM ET
    $ROG
    Major Chemicals
    Industrials

    $ROG
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Rogers Corporation

    SC 13G/A - ROGERS CORP (0000084748) (Subject)

    11/12/24 12:54:21 PM ET
    $ROG
    Major Chemicals
    Industrials

    SEC Form SC 13G/A filed by Rogers Corporation (Amendment)

    SC 13G/A - ROGERS CORP (0000084748) (Subject)

    2/13/24 5:14:06 PM ET
    $ROG
    Major Chemicals
    Industrials

    SEC Form SC 13G filed by Rogers Corporation

    SC 13G - ROGERS CORP (0000084748) (Subject)

    2/9/24 5:49:06 PM ET
    $ROG
    Major Chemicals
    Industrials